A compound selected from the group consisting of an isoquinoline-5-carboxamide derivative of formula (I), a pharmaceutically acceptable salt, an isomer, a hydrate and a solvate thereof is effective for the prevention or treatment of diseases associated with abnormal cell growth, which are caused by abnormal activation of a protein kinases.
从以下组合中选择的化合物,包括公式(I)的
异喹啉-5-羧酰胺衍
生物,其药学上可接受的盐,异构体,
水合物和溶剂化物,对于预防或治疗由蛋白激酶异常激活引起的异常细胞增殖相关疾病是有效的。